Optimizing regional infusion treatment strategies for melanoma of the extremities

Por Coleman, Andrew, Augustine, Christina K, Beasley, Georgia, Sanders, Gretchen, Tyler, Douglas
Publicado em 2009

Use of Gene Expression and Pathway Signatures to Characterize the Complexity of Human Melanoma

Por Freedman, Jennifer A., Tyler, Douglas S., Nevins, Joseph R., Augustine, Christina K.
Publicado em 2011

Src Family Kinase Inhibition as a Novel Strategy to Augment Melphalan-Based Regional Chemotherapy of Advanced Extremity Melanoma

Por Tokuhisa, Yoshihiro, Lidsky, Michael E., Toshimitsu, Hiroaki, Turley, Ryan S., Beasley, Georgia M., Ueno, Tomio, Sharma, Ketan, Augustine, Christina K., Tyler, Douglas S.
Publicado no Ann Surg Oncol (2013)

CYLD inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathways

Por Ke, Hengning, Augustine, Christina K, Gandham, Vineela D, Jin, Jane Y, Tyler, Douglas S, Akiyama, Steven K, Hall, Russell P, Zhang, Jennifer Y
Publicado em 2012

Current Trends in Regional Therapy for Melanoma: Lessons Learned from 225 Regional Chemotherapy Treatments between 1995 and 2010 at a Single Institution

Por Raymond, Amanda K, Beasley, Georgia M, Broadwater, Gloria, Augustine, Christina K, Padussis, James C, Turley, Ryan, Peterson, Bercedis, Seigler, Hilliard, Pruitt, Scott K, Tyler, Douglas S
Publicado em 2011

Prospective Multicenter Phase II Trial of Systemic ADH-1 in Combination With Melphalan via Isolated Limb Infusion in Patients With Advanced Extremity Melanoma

Por Beasley, Georgia M., Riboh, Jonathan C., Augustine, Christina K., Zager, Jonathan S., Hochwald, Steven N., Grobmyer, Stephen R., Peterson, Bercedis, Royal, Richard, Ross, Merrick I., Tyler, Douglas S.
Publicado no J Clin Oncol (2011)

A Multi-center Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-arterial Temozolomide for Patients with Advanced Extremity Melanoma Using Normothermic Iso...

Por Beasley, Georgia M., Speicher, Paul, Augustine, Christina K., Dolber, Paul C., Peterson, Bercedis L., Sharma, Ketan, Mosca, Paul J., Royal, Richard, Ross, Merrick, Zager, Jonathan S., Tyler, Douglas S.
Publicado no Ann Surg Oncol (2014)

Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit Melanoma

Por Turley, Ryan S., Fontanella, Andrew N., Padussis, James C., Toshimitsu, Hiroaki, Tokuhisa, Yoshihiro, Cho, Eugenia H., Hanna, Gabi, Beasley, Georgia M., Augustine, Christina K., Dewhirst, Mark W., Tyler, Douglas S.
Publicado em 2012

A methodology for utilization of predictive genomic signatures in FFPE samples

Por Freedman, Jennifer A, Augustine, Christina K, Selim, Angelica M, Holshausen, Kirsten C, Wei, Zhengzheng, Tsamis, Katherine A, Hsu, David S, Dressman, Holly K, Barry, William T, Tyler, Douglas S, Nevins, Joseph R
Publicado em 2011

Targeting N-cadherin Increases Vascular Permeability and Differentially Activates AKT in Melanoma

Por Turley, Ryan S., Tokuhisa, Yoshihiro, Toshimitsu, Hiroaki, Lidsky, Michael E., Padussis, James C., Fontanella, Andrew, Deng, Wanleng, Augustine, Christina K., Beasley, Georgia M., Davies, Michael. A., Dewhirst, Mark W., Tyler, Douglas S.
Publicado no Ann Surg (2015)